Cefazolin Syringes Recalled Due to Lack of Sterility Assurance
CMC Enterprise Pharmacy is recalling 475 cefazolin syringes distributed in North Carolina because they lack sterility assurance.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II and involves a risk-of-harm product (lack of sterility assurance) where injury has not yet been reported, which aligns with the High severity criteria.
Plain-English summary
CMC Enterprise Pharmacy is recalling 475 syringes of Cefazolin 3 gm 100 mg/mL, 30 mL. The recall is due to a lack of sterility assurance. The product was distributed in North Carolina.
The affected lots include EB281907, EC011905, EC071907, EC081908, EC131906, EC141906, EC151919, EC181907, EC201906, EC211907, EC221908, EC251907, EC261907, EC271907, EC281907, EC011907, ED021909, ED031907, ED041906, ED051908, ED081907, and ED091907. These lots have expiration dates ranging from April 14, 2019, to May 24, 2019.
Consumers and healthcare providers should stop using the recalled product and contact the recalling firm for further instructions.
The recalled product
- Product
- CeFAZolin 3 gm 100 mg/mL, 30 mL syringe, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.
- Manufacturer
- CMC Enterprise Pharmacy
- Category
- Drug — Antibiotic
- Hazard
- Affected units
- 475
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lots: EB281907 Exp. 4/14/2019
- EC011905 Exp. 4/15/2019
- EC071907 Exp. 4/21/2019
- EC081908 Exp. 4/22/2019
- EC131906 Exp. 4/27/2019
- EC141906 Exp. 4/28/2019
- EC151919 Exp. 4/29/2019
- EC181907 Exp. 5/2/2019
- EC201906 Exp. 5/4/2019
- EC211907 Exp. 5/5/2019
- EC221908 Exp. 5/6/2019
- EC251907 Exp. 5/9/2019
- EC261907 Exp. 5/10/2019
- EC271907 Exp. 5/11/2019
- EC281907 Exp. 5/12/2019
- EC011907 Exp. 5/16/2019
- ED021909 Exp. 5/17/2019
- ED031907 Exp. 5/18/2019
- ED041906 Exp. 5/19/2019
- ED051908 Exp. 5/20/2019
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 32 recalled by CMC Enterprise Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 32 products in this recall →Related recalls
Same manufacturer · CMC Enterprise Pharmacy
See all →- SevereCMC Enterprise Pharmacy Recalls CeFAZolin Due to Lack of Sterility Assurance
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls Oxytocin Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls Vancomycin Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
- SevereDiltiazem 250 mg IV Bags Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls Magnesium Sulfate Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15